Cargando…

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany

BACKGROUND: This study aimed to determine the number of people living with HIV receiving antiretroviral therapy (ART) between 2006 and 2013 in Germany by using the available numbers of antiretroviral drug prescriptions and treatment data from the ClinSurv HIV cohort (CSH). METHODS: The CSH is a mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Daniel, Kollan, Christian, Stoll, Matthias, Stellbrink, Hans-Jürgen, Plettenberg, Andreas, Fätkenheuer, Gerd, Bergmann, Frank, Bogner, Johannes R, van Lunzen, Jan, Rockstroh, Jürgen, Esser, Stefan, Jensen, Björn-Erik Ole, Horst, Heinz-August, Fritzsche, Carlos, Kühne, Andrea, an der Heiden, Matthias, Hamouda, Osamah, Bartmeyer, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369891/ https://www.ncbi.nlm.nih.gov/pubmed/25848706 http://dx.doi.org/10.1186/s12889-015-1598-4

Ejemplares similares

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
por: Stoll, Matthias, et al.
Publicado: (2011)

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany
por: Schmidt, Daniel, et al.
Publicado: (2014)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)
por: Schmidt, Daniel, et al.
Publicado: (2021)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2020)

Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2021)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines
por: Treskova, Marina, et al.
Publicado: (2016)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
por: Altmann, Mathias, et al.
Publicado: (2012)

Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy
por: Karo, Basel, et al.
Publicado: (2017)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

HIV-induced immune activation - pathogenesis and clinical relevance. Summary of a workshop organised by the German AIDs Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008
por: Stellbrink, HJ, et al.
Publicado: (2010)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)
por: Schäfer, Guido, et al.
Publicado: (2019)

Managing antiretrovirals in co-infected patients in 2012
por: Rockstroh, Jürgen
Publicado: (2012)

The denominator problem: Estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys
por: Marcus, Ulrich, et al.
Publicado: (2009)

Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease
por: Kastenbauer, U, et al.
Publicado: (2009)

Mycotic Brain Abscess Caused by Opportunistic Reptile Pathogen
por: Steininger, Christoph, et al.
Publicado: (2005)

Intermittent viraemia and immune reconstitution in patients with more than 10–15 years of antiretroviral therapy: baseline values still matter
por: Erdbeer, Gesa, et al.
Publicado: (2014)

Everything fine so far? Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy
por: Erdbeer, Gesa, et al.
Publicado: (2014)

The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
por: Tenner-Racz, Klara, et al.
Publicado: (1998)

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
por: Sax, Paul E, et al.
Publicado: (2019)

Atripla™ – HIV therapy in one pill
por: Julg, Boris, et al.
Publicado: (2008)

The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany
por: Mahlich, Jörg, et al.
Publicado: (2016)

1269. Cohort Profile: The Translational Platform HIV (TP-HIV), a Multicenter Cohort Project in Germany
por: Stecher, Melanie, et al.
Publicado: (2019)

Trouble with Bleeding: Risk Factors for Acute Hepatitis C among HIV-Positive Gay Men from Germany—A Case-Control Study
por: Schmidt, Axel J., et al.
Publicado: (2011)

Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report
por: Schewe, Knud, et al.
Publicado: (2010)

HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance
por: Geretti, Anna Maria, et al.
Publicado: (2022)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

Once-daily S/GSK1349572 combination therapy in antiretroviral-naïve adults: rapid and potent 24-week antiviral responses in SPRING-1 (ING112276)
por: Rockstroh, J, et al.
Publicado: (2010)

Raltegravir in the management of HIV-infected patients
por: Stellbrink, Hans-Jürgen
Publicado: (2009)

Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection
por: Stellbrink, Hans-Jürgen
Publicado: (2010)

Should we avoid protease inhibitors in first lines due to their lipid side effects? - cons
por: Stellbrink, Hans-Jürgen
Publicado: (2014)

Das Lagemanagement des Robert Koch-Instituts während der COVID-19-Pandemie und der Austausch zwischen Bund und Ländern
por: Halm, Ariane, et al.
Publicado: (2021)

Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients
por: Lehmann, Clara, et al.
Publicado: (2010)

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion
por: Rüsenberg, Robin, et al.
Publicado: (2021)

HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi
por: Demir, Münevver, et al.
Publicado: (2016)

Treatment strategies for treatment naïve HIV patients in Germany: evidence from claims data
por: Mahlich, Jörg, et al.
Publicado: (2015)

The Use of Pill Counts as a Facilitator of Adherence with Antiretroviral Therapy in Resource Limited Settings
por: Achieng, Loice, et al.
Publicado: (2013)

Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing
por: Rauschning, Dominic, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p7tbglu500cu3sj3n88644vcvr